ACNP - Italian Periodicals Catalogue

AAAAAA

ITA
ENG

Results: 1-20 |

Results: 20

LONG-TERM FOLLOW-UP OF THE ITALIAN TRIAL OF INTERFERON-ALPHA VERSUS CONVENTIONAL CHEMOTHERAPY IN CHRONIC MYELOID-LEUKEMIA

Authors: TURA S ROSTI G DEVIVO A BONIFAZI F FIACCHINI M BACCARANI M RUSSO D FANIN R ZUFFA E MONTEFUSCO E

Citation: S. Tura et al., LONG-TERM FOLLOW-UP OF THE ITALIAN TRIAL OF INTERFERON-ALPHA VERSUS CONVENTIONAL CHEMOTHERAPY IN CHRONIC MYELOID-LEUKEMIA, Blood, 92(5), 1998, pp. 1541-1548

HIGH BCL-2 EXPRESSION IN ACUTE MYELOID-LEUKEMIA CELLS CORRELATES WITHCD34 POSITIVITY AND COMPLETE REMISSION RATE

Authors: LAURIA F RASPADORI D RONDELLI D VENTURA MA FIACCHINI M VISANI G FORCONI F TURA S

Citation: F. Lauria et al., HIGH BCL-2 EXPRESSION IN ACUTE MYELOID-LEUKEMIA CELLS CORRELATES WITHCD34 POSITIVITY AND COMPLETE REMISSION RATE, Leukemia, 11(12), 1997, pp. 2075-2078

EPIDEMIOLOGIC, DIAGNOSTIC, THERAPEUTIC AND PROGNOSTIC ASPECTS OF ESSENTIAL THROMBOCYTHEMIA IN A RETROSPECTIVE STUDY OF THE GIMMC-GROUP IN 2,000 PATIENTS

Authors: GUGLIOTTA L MARCHIOLI R FIACCHINI M VIANELLI N BARAVELLI S VALDRE L DEVIVO A MARFISI R RADAELLI F GARGANTINI L AMBROSETTO A MAZZUCCONI MG RUSSO D BAZZAN M ZACCARIA A FINAZZI G GROSSI A RUGGERI M POGLIANI E SACCHI S MARTINELLI V BARBUI T LAZZARINO M

Citation: L. Gugliotta et al., EPIDEMIOLOGIC, DIAGNOSTIC, THERAPEUTIC AND PROGNOSTIC ASPECTS OF ESSENTIAL THROMBOCYTHEMIA IN A RETROSPECTIVE STUDY OF THE GIMMC-GROUP IN 2,000 PATIENTS, Blood, 90(10), 1997, pp. 1551-1551

RANDOMIZED TRIAL OF AUTOLOGOUS FILGRASTIM-PRIMED BONE-MARROW TRANSPLANTATION VERSUS FILGRASTIM-MOBILIZED PERIPHERAL-BLOOD STEM-CELL TRANSPLANTATION IN LYMPHOMA PATIENTS

Authors: DAMIANI D FANIN R SILVESTRI F GRIMAZ S INFANTI L GEROMIN A CERNO M MICHIELI M RINALDI C SAVIGNANO C TRANI G FIACCHINI M BACCARANI M

Citation: D. Damiani et al., RANDOMIZED TRIAL OF AUTOLOGOUS FILGRASTIM-PRIMED BONE-MARROW TRANSPLANTATION VERSUS FILGRASTIM-MOBILIZED PERIPHERAL-BLOOD STEM-CELL TRANSPLANTATION IN LYMPHOMA PATIENTS, Blood, 90(1), 1997, pp. 36-42

AUTOLOGOUS BONE-MARROW TRANSPLANTATION IN LATE FIRST COMPLETE REMISSION IMPROVES OUTCOME IN ACUTE MYELOGENOUS LEUKEMIA

Authors: MIGGIANO MC GHERLINZONI F ROSTI G BANDINI G VISANI G FIACCHINI M RICCI P TESTONI N MOTTA MR GEROMIN A RIZZI S BELARDINELLI A MANGIANTI S MANFROI S TURA S

Citation: Mc. Miggiano et al., AUTOLOGOUS BONE-MARROW TRANSPLANTATION IN LATE FIRST COMPLETE REMISSION IMPROVES OUTCOME IN ACUTE MYELOGENOUS LEUKEMIA, Leukemia, 10(3), 1996, pp. 402-409

HIGH-DOSE CHEMOTHERAPY FOLLOWED BY AUTOLOGOUS BONE-MARROW TRANSPLANTATION VERSUS DEXAMETHASONE, CISPLATIN, AND CYTARABINE IN AGGRESSIVE NON-HODGKINS-LYMPHOMA WITH PARTIAL-RESPONSE TO FRONT-LINE CHEMOTHERAPY - A PROSPECTIVE RANDOMIZED ITALIAN MULTICENTER STUDY

Authors: MARTELLI M VIGNETTI M ZINZANI PL GHERLINZONI F MELONI G FIACCHINI M DESANCTIS V PAPA G MARTELLI MF CALABRESI F TURA S MANDELLI F

Citation: M. Martelli et al., HIGH-DOSE CHEMOTHERAPY FOLLOWED BY AUTOLOGOUS BONE-MARROW TRANSPLANTATION VERSUS DEXAMETHASONE, CISPLATIN, AND CYTARABINE IN AGGRESSIVE NON-HODGKINS-LYMPHOMA WITH PARTIAL-RESPONSE TO FRONT-LINE CHEMOTHERAPY - A PROSPECTIVE RANDOMIZED ITALIAN MULTICENTER STUDY, Journal of clinical oncology, 14(2), 1996, pp. 534-542

CARDIAC INJURY AS LATE TOXICITY OF MEDIASTINAL RADIATION-THERAPY FOR HODGKINS-DISEASE PATIENTS

Authors: ZINZANI PL GHERLINZONI F PIOVACCARI G FREZZA G BENDANDI M FERRETTI RM BARBIERI E FIACCHINI M BABINI L MAGNANI B TURA S

Citation: Pl. Zinzani et al., CARDIAC INJURY AS LATE TOXICITY OF MEDIASTINAL RADIATION-THERAPY FOR HODGKINS-DISEASE PATIENTS, Haematologica, 81(2), 1996, pp. 132-137

IMMUNOLOGICAL AND CLINICAL MODIFICATIONS FOLLOWING LOW-DOSE SUBCUTANEOUS ADMINISTRATION OF RIL-2 IN NON-HODGKINS-LYMPHOMA PATIENTS AFTER AUTOLOGOUS BONE-MARROW TRANSPLANTATION

Authors: LAURIA F RASPADORI D VENTURA MA RONDELLI D ZINZANI PL GHERLINZONI F MIGGIANO MC FIACCHINI M ROSTI G RIZZI S TURA S

Citation: F. Lauria et al., IMMUNOLOGICAL AND CLINICAL MODIFICATIONS FOLLOWING LOW-DOSE SUBCUTANEOUS ADMINISTRATION OF RIL-2 IN NON-HODGKINS-LYMPHOMA PATIENTS AFTER AUTOLOGOUS BONE-MARROW TRANSPLANTATION, Bone marrow transplantation, 18(1), 1996, pp. 79-85

MACOP-B VS F-MACHOP REGIMEN IN THE TREATMENT OF HIGH-GRADE NON-HODGKINS-LYMPHOMAS

Authors: MAZZA P ZINZANI PL MARTELLI M FIACCHINI M BOCCHIA M PILERI S FALINI B MARTELLI MF AMADORI S PAPA G CANTONETTI M LUCARELLI G MORETTI L CALABRESI F RUGGERI E GHERLINZONI F BENDANDI M GUGLIELMI C BURGIO V DAMMACCO F LAUTA VM LIBERATI AM MANDELLI F TURA S

Citation: P. Mazza et al., MACOP-B VS F-MACHOP REGIMEN IN THE TREATMENT OF HIGH-GRADE NON-HODGKINS-LYMPHOMAS, Leukemia & lymphoma, 16(5-6), 1995, pp. 457-463

RADIOTHERAPY IN EARLY-STAGE HODGKINS-DISEASE

Authors: ZINZANI PL BARBIERI E GHERLINZONI F FREZZA G MAZZA P PICA A AMMENDOLIA I BENDANDI M NERI S MINIACI G FIACCHINI M BABINI L TURA S

Citation: Pl. Zinzani et al., RADIOTHERAPY IN EARLY-STAGE HODGKINS-DISEASE, Leukemia & lymphoma, 13(3-4), 1994, pp. 285-289

SERUM LEVELS OF SOLUBLE CD30 ARE ELEVATED IN THE MAJORITY OF UNTREATED PATIENTS WITH HODGKINS-DISEASE AND CORRELATE WITH CLINICAL-FEATURES AND PROGNOSIS

Authors: NADALI G VINANTE F AMBROSETTI A TODESCHINI G VENERI D ZANOTTI R MENEGHINI V RICETTI MM BENEDETTI F VASSANELLI A PERONA G CHILOSI M MENESTRINA F FIACCHINI M STEIN H PIZZOLO G

Citation: G. Nadali et al., SERUM LEVELS OF SOLUBLE CD30 ARE ELEVATED IN THE MAJORITY OF UNTREATED PATIENTS WITH HODGKINS-DISEASE AND CORRELATE WITH CLINICAL-FEATURES AND PROGNOSIS, Journal of clinical oncology, 12(4), 1994, pp. 793-797

CEP REGIMEN (CCNU, ETOPOSIDE, PREDNIMUSTINE) FOR RELAPSED REFRACTORY HODGKINS-DISEASE

Authors: ZINZANI PL BARBIERI E BENDANDI M PERINI F GHERLINZONI F NERI S AMMENDOLIA I SALVUCCI M BABINI L FIACCHINI M TURA S

Citation: Pl. Zinzani et al., CEP REGIMEN (CCNU, ETOPOSIDE, PREDNIMUSTINE) FOR RELAPSED REFRACTORY HODGKINS-DISEASE, Tumori, 80(6), 1994, pp. 438-442

INTERFERON ALFA-2A AS COMPARED WITH CONVENTIONAL CHEMOTHERAPY FOR THETREATMENT OF CHRONIC MYELOID LEUKEMIA

Authors: TURA S BACCARANI M ZUFFA E RUSSO D ZACCARIA A FIACCHINI M TESTONI N ZAMAGNI MD MARTINELLI G DAMIANI D MICHIELI M FOWST C HOLDENER EE SPECCHIA G LISO V MORRA E BERNASCONI C ALIMENA G MANDELLI F LEONI P DANIELI G NOSARI A DECATALDO F MAJOLINO I CARONIA F LIBERATI AM GRIGNANI F TABILIO A MARTELLI M PAOLINO F RESEGOTTI L DITUCCI A BROCCIA G LEONI F CIOLLI S LUCIANO L ROTOLI B PERRICONE R CAJOZZO A MONTUORO A DELAURENZI A VOLPE E DEMILIO A BATTISTA R CAPUCCI A IZZI T SCAPOLI GL CASTOLDI GL LOMBARDO M TORLONTANO G LANDOLFI R LEONE G DELFINI C SPARAVENTI G PAPINESCHI F SPREMOLLA G RISSO M MARMONT AM DINI D DIPRISCO U MANGONI L RIZZOLI V GIRINO M ASCARI E BODENIZZA CA CAROTENUTO M DIFRANCESCO A QUAGLINO D NARDELLI S CICCONE F MIRAGLIA E DEBIASE R GALLO E PILERI A RAMBALDI A BARBUI T MORANDI S BIANCHINI E DEROSA C CIMINO R RONCA F NOBILE F CANTONETTI M PAPA G GALLAMINI A BUFFA F MUSOLINO C SQUADRITO G CAPALDI A GIOVANNELLI E PINOTTI G VENCO A ZAGONEL V PINTO A GENTILINI I COSER P GUGLIELMO P CACCIOLA E PIZZUTI M RICCIUTI F FANIN R CRISCUOLO D MONTEFUSCO E

Citation: S. Tura et al., INTERFERON ALFA-2A AS COMPARED WITH CONVENTIONAL CHEMOTHERAPY FOR THETREATMENT OF CHRONIC MYELOID LEUKEMIA, The New England journal of medicine, 330(12), 1994, pp. 820-825

PROGNOSTIC FACTORS IN CHRONIC MYELOID-LEUKEMIA - RELATIONSHIP WITH INTERFERON AND BONE-MARROW TRANSPLANTATION

Authors: TURA S RUSSO D FANIN R ZUFFA E PATRIARCA F FIACCHINI M BACCARANI M TESTONI N ZAMAGNI MD ZACCARIA A MONTEFUSCO E ALIMENA G MELONI G MANDELLI F DAMIANI D MICHIELI M SILVESTRI F VIRGOLINI L CRISCUOLO D FOWST C HOLDENER EE SPECCHIA G LISO V MORRA E BERNASCONI C DEMILIO A BATTISTA R DITUCCI A BROCCIA G MAJOLINO I CARONIA F LUCIANO L ROTOLI B LEONI P BODENIZZA CA CAROTENUTO M ROTONDO SG NOSARI A DECATALDO F MONTUORO A DELAURENZI A LIBERATI AM TABILIO A MARTELLI M RAMBALDI A BARBUI T LEONI F CIOLLI S RONCA F NOBILE F PAOLINO F RESEGOTTI L PAPINESCHI F SPREMOLLA G LANDOLFI R LEONE G VOLPE E MANGONI L RIZZOLI V CAPUCCI A IZZI T GENTILINI I COSER P GALLO E PILERI A CANTONETTI M PAPA G DINI D DIPRISCO U MORANDI S BIANCHINI E PINOTTI G VENCO A ZAGONEL V PINTO A CAPALDI A GIOVANNELLI E PIZZUTI M RICCIUTI F AMBROSETTI A PERONA G PERRICONE R CAJOZZO A LOMBARDO M TORLONTANO G DELFINI C LUCARELLI G GIRINO M ASCARI E

Citation: S. Tura et al., PROGNOSTIC FACTORS IN CHRONIC MYELOID-LEUKEMIA - RELATIONSHIP WITH INTERFERON AND BONE-MARROW TRANSPLANTATION, Leukemia & lymphoma, 11, 1993, pp. 67-71

WILL MOLECULAR-BIOLOGY CONTRIBUTE TO REFINE PROGNOSIS AND TO SELECT TREATMENT

Authors: ZACCARIA A MARTINELLI G BUZZI M FARABEGOLI P SAGLIO G GUERRASIO A BERNABEI PA SANTINI V PELLICCI PG MENCARELLI A COCO FL DIVERIO D RAMBALDI A SANTORO A TURA S RUSSO D ZUFFA E FANIN R PATRIARCA F FIACCHINI M BACCARANI M TESTONI N ZAMAGNI MD ZACCARIA A MONTEFUSCO E ALIMENA G MELONI G MANDELLI F DAMIANI D MICHIELI M CRISCUOLO D FOWST C HOLDENER EE SPECCHIA G LISO V MORRA E BERNASCONI C DEMILIO A BATTISTA R DITUCCI A BROCCIA G MAIOLINO I CARONIA F LUCIANO L ROTOLI B LEONI P DANIELI G BODENIZZA CA CAROTENUTO M ROTONDO SG NOSARI A DECATALDO F MONTUORO A DELAURENZI A CAMILLO S LIBERATI AM GRIGNANI F TABILIO A MARTELLI M RAMBALDI A BARBUI T LEONI F CIOLLI S RONCA F NOBILE F PAOLINO F RESEGOTTI L PAPINESCHI F SPREMOLLA G LANDOLFI R LEONE G VOLPE E MANGONI L RIZZOLI V CAPUCCI A IZZI T SCAPOLI GL CASTOLDI GL GENTILINI I COSER P GALLO E PILERI A CANTONETTI M PAPA G DINI D MORANDI S BIANCHINI E PINOTTI G VENCO A ZAGONEL V PINTO A CAPALDI A GIOVANNELLI E PIZZUTI M RICCIUTI F AMBROSETTI A CAJOZZO A LOMBARDO M TORLONTANO G DELFINI C LUCARELLI G GIRINO M ASCARI E RISSO M DAMASIO E MARTINO S PARDINI S LONGINOTTI M MIRAGLIA E DEBIASE R NARDELLI S GALIENI P DISPENSA E ABBADESSA A BRUZZESE L PROSSOMARITI L CIMINO R DEROSA C GABBAS A FRANCESCO S GALLAMINI A DIFRANCESCO A QUAGLINO D MUSOLINO C SQUADRITO G AVANZINI P GOBBI F NUOVA ASM EMILIA R SAGLIO G AGLIETTA M CAMASCHELLA C MAZZA MU GUGLIELMO P CACCIOLA E MONACO M

Citation: A. Zaccaria et al., WILL MOLECULAR-BIOLOGY CONTRIBUTE TO REFINE PROGNOSIS AND TO SELECT TREATMENT, Leukemia & lymphoma, 11, 1993, pp. 81-89

TREATMENT OF PH-POSITIVE CHRONIC MYELOID-LEUKEMIA WITH ALPHA-INTERFERON (ROFERON-A) - THE ITALIAN COOPERATIVE STUDY-GROUP EXPERIENCE

Authors: TURA S RUSSO D ZUFFA E FANIN R PATRIARCA F FIACCHINI M BACCARANI M TESTONI N ZAMAGNI MD ZACCARIA A MONTEFUSCO E ALIMENA G MELONI G MANDELLI F DAMIANI D MICHIELI M CRISCUOLO D FOWST C HOLDENER EE SPECCHIA G LISO V MORRA E BERNASCONI C DEMILIO A BATTISTA R DITUCCI A BROCCIA G MAIOLINO I CARONIA F LUCIANO L ROTOLI B LEONI P DANIELI G BODENIZZA CA CAROTENUTO M ROTONDO SG NOSARI A DECATALDO F MONTUORO A DELAURENZI A CAMILLO S LIBERATI AM GRIGNANI F TABILIO A RAMBALDI A BARBUI T LEONI F CIOLLI S RONCA F NOBILE F PAOLINO F RESEGOTTI L PAPINESCHI F SPREMOLLA G LANDOLFI R LEONE G VOLPE E MANGONI L RIZZOLI V CAPUCCI A IZZI T SCAPOLI GL CASTOLDI GL GENTILINI I COSER P GALLO E PILERI A CANTONETTI M PAPA G DINI D DIPRISCO U MORANDI S BIANCHINI E PINOTTI G VENCO A ZAGONEL V PINTO A CAPALDI A GIOVANNELLI E PIZZUTI M RICCIUTI F AMBROSETTI A PERONA G PERRICONE R CAJOZZO A LOMBARDO M TORLONTANO G DELFINI C LUCARELLI G GIRINO M ASCARI E RISSO M DAMASIO E MARTINO S PARDINI S LONGINOTTI M MIRAGLIA E DEBIASE R NARDELLI S CICCONE F GALIENI P DISPENSA E ABBADESSA A BRUZZESE L PROSSOMARITI L CIMINO R DEROSA C GABBAS A FRANCESCO S GALLAMINI A DIFRANCESCO A QUAGLINO D MUSOLINO C SQUADRITO G AVANZINI P GOBBI F NUOVA ASM EMILIA R SAGLIO G AGLIETTA M CAMASCHELLA C MAZZA MU GUGLIELMO P CACCIOLA E MONACO M

Citation: S. Tura et al., TREATMENT OF PH-POSITIVE CHRONIC MYELOID-LEUKEMIA WITH ALPHA-INTERFERON (ROFERON-A) - THE ITALIAN COOPERATIVE STUDY-GROUP EXPERIENCE, Leukemia & lymphoma, 11, 1993, pp. 153-157

KARYOTYPIC CONVERSION BY INTERFERON AS PREPARATIVE TREATMENT FOR AUTOLOGOUS BMT IN PH POSITIVE CML

Authors: GOBBI M TURA S RUSSO D ZUFFA E PATRIARCA F FIACCHINI M GOBBI M BACCARANI M MONTEFUSCO E MELONI G MANDELLI F ZAMAGNI MD TESTONI N ZACCARIA A FANIN R DAMIANI D MICHIELI M CRISCUOLO D FOWST C HOLDENER EE SPECCHIA G LISO V DEMILIO A BATTISTA R DITUCCI A BROCCIA G BODENIZZA CA CAROTENUTO M ROTONDO G AMBROSETTI A PERONA G MAJOLINO I CARONIA F LUCIANO L ROTOLI B MORRA E BERNASCONI C RAMBALDI A BARBUI T RONCO F NOBILE F LEONI P NOSARI A DECATALDO F MONTUORO A DELAURENZI A CAMILLO S GENTILINI I COSER P DINI D DIPRISCO U PAPINESCHI F SPREMOLLA G LIBERATI A GRIGNANI G TABILIO A MARTELLI M PARDINI S LONGINOTTI M MANGONI L RIZZOLI V GALIENI P DISPENSA E ABBADESSA A BRUZZESE L LEONI F CIOLLI S CANTONETTI M PAPA G LANDOLFI R LEONE G GALLO E PILERI A ZAGONEL V PINTO A VOLPE E DIFRANCESCO A QUAGLINO D AVANZINI P GOBBI F PAOLINO F RESEGOTTI L SAGLIO G CAMASCHELLA C MAZZA U PINOTTI G VENCO G CAPUCCI A IZZI T MORANDI S BIANCHINI E SCAPOLI GL MONACO M PIZZUTI M RICCIUTI F CAPALDI A GIOVANNELLI E

Citation: M. Gobbi et al., KARYOTYPIC CONVERSION BY INTERFERON AS PREPARATIVE TREATMENT FOR AUTOLOGOUS BMT IN PH POSITIVE CML, Leukemia & lymphoma, 11, 1993, pp. 277-280

FLUDARABINE IN PATIENTS WITH ADVANCED AND OR RESISTANT B-CHRONIC LYMPHOCYTIC-LEUKEMIA

Authors: ZINZANI PL LAURIA F RONDELLI D BENFENATI D RASPADORI D BOCCHIA M GOZZETTI A CAVO M CIRIO TM ZAJA F RUSSO D FANIN R GALIENI P ALGERI R FIACCHINI M TURA S

Citation: Pl. Zinzani et al., FLUDARABINE IN PATIENTS WITH ADVANCED AND OR RESISTANT B-CHRONIC LYMPHOCYTIC-LEUKEMIA, European journal of haematology, 51(2), 1993, pp. 93-97

SPLENECTOMY AND THE INCREASING RISK OF SECONDARY ACUTE-LEUKEMIA IN HODGKINS-DISEASE

Authors: TURA S FIACCHINI M ZINZANI PL BRUSAMOLINO E GOBBI PG

Citation: S. Tura et al., SPLENECTOMY AND THE INCREASING RISK OF SECONDARY ACUTE-LEUKEMIA IN HODGKINS-DISEASE, Journal of clinical oncology, 11(5), 1993, pp. 925-930

EVALUATING SURVIVAL AFTER ALLOGENEIC BONE-MARROW TRANSPLANT FOR CHRONIC MYELOID-LEUKEMIA IN CHRONIC PHASE - A COMPARISON OF TRANSPLANT VERSUS NO-TRANSPLANT IN A COHORT OF 258 PATIENTS 1ST SEEN IN ITALY BETWEEN1984 AND 1986

Authors: TURA S FANIN R RUSSO D ZUFFA F FIACCHINI M BACCARANI M TESTONI N ZAMAGNI D ZACCARIA A DAMIANI D MICHIELI M ALIMENA G MONTEFUSCO E MANDELLI F MORRA E BERNASCONI C GUGLIELMI P CACCIOLA E BATTISTA R DINI E SPECCHIA G LISO V MAJOLINO I CARONIA F LEONI P DANIELI G NOSARI A DECATALDO F PAOLINO F RESEGOTTI L COMOTTI B BARBUI T SCAPOLI GL CASTOLDI GL PROSSOMARITI L MONTUORI R RICCARDI A ASCARI E LANDOLFI R BIZZI B LOMBARDO M TORLONTANO G LEONI F FERRINI PR SPARAVENTI G DELFINI C PAPINESCHI F SPREMOLLA G BROCCIA G NARDELLI S CICCONE F DERIU L MIRAGLIA E DEBIASE R BODENIZZA CA CAROTENUTO M ROTONDO SG GENTILINI I COSER P CAPUCCI A IZZI T LUCIANO L ROTOLI B IACOPINO P NOBILE F CANTONETTI M PAPA G PINOTTI G SALA G FOA P MAIOLO MT AVANZINI P GOBBI F DORE F PARDINI S AMBROSETTI A PERONA G DINI D LIBERATI AM MARTELLI M GRIGNANI F MONTUORO A DELAURENZI A GALLO E PILERI A GALLAMINI A BUFFA F ABBADESSA A BRUZZESE L DEROSA C CIMINO R MANGONI L RIZZOLI V PIZZUTI M RICCIUTI F GALIENI P DISPENSA E ZAGONEL V PINTO A MUSOLINO C SQUADRITO G PERRICONE R CAJOZZO A MORANDI S BIANCHINI E MILIANI A MONACO M DIFRANCESCO A QUAGLINO D ROSTI G MARANGOLO M PASINI FL DIPERRI T AGLIETTA M GAVOSTO F

Citation: S. Tura et al., EVALUATING SURVIVAL AFTER ALLOGENEIC BONE-MARROW TRANSPLANT FOR CHRONIC MYELOID-LEUKEMIA IN CHRONIC PHASE - A COMPARISON OF TRANSPLANT VERSUS NO-TRANSPLANT IN A COHORT OF 258 PATIENTS 1ST SEEN IN ITALY BETWEEN1984 AND 1986, British Journal of Haematology, 85(2), 1993, pp. 292-299

Risultati: 1-20 |